Anti-HER2 CD4+ T-helper type 1 response is a novel immune correlate to pathologic response following neoadjuvant therapy in HER2-positive breast cancer

Overview of attention for article published in Breast Cancer Research, May 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (77th percentile)
Good Attention Score compared to outputs of the same age and source (78th percentile)

So far, Altmetric has seen 6 X posts from 6 X users, with an upper bound of 44,595 followers.

#BreastCancerRes Anti-HER2 CD4(+) T-helper type 1 response is a novel immune correlate to pathologic response… https://t.co/K12Qs3hLWm

Anti-HER2 CD4+ T-helper type 1 response following neoadjuvant therapy in HER2-positive breast ca... - PubMed - NCBI http://t.co/fpsQ9dC0sI

Anti-HER2 T-helper-cell response correlated with pathological response to neoadjuvant therapy in HER2+ #breastcancer. http://t.co/UlooUV3HDH

Anti-HER2 T-helper-cell response correlated with pathological response to neoadjuvant therapy in HER2+ #breastcancer. http://t.co/UlooUV3HDH

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.